WELCHOL

Peak

colesevelam hydrochloride

NDAORALBAR, CHEWABLE

Approved

Apr 2019

Lifecycle

Peak

Competitive Pressure

30/100

Clinical Trials

NCT00993824Phase 2/3Completed

Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes

Started Sep 2009

21 enrolled

Type 2 Diabetes

NCT00951899Phase 4Completed

The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics

Started Aug 2009

38 enrolled

Type 2 Diabetes

NCT00789737Phase 3Completed

Welchol as Monotherapy for Type 2 Diabetes Mellitus

Started Jan 2009

357 enrolled

Type 2 Diabetes Mellitus

NCT00361153Phase 2Completed

Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

Started May 2006

35 enrolled

Type 2 Diabetes Mellitus

NCT00151762Phase 3Completed

Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes

Started Dec 2004

780 enrolled

Type 2 Diabetes

External Resources